» Articles » PMID: 37770747

Genomic Epidemiology Reveals Multidrug Resistant Plasmid Spread Between Vibrio Cholerae Lineages in Yemen

Abstract

Since 2016, Yemen has been experiencing the largest cholera outbreak in modern history. Multidrug resistance (MDR) emerged among Vibrio cholerae isolates from cholera patients in 2018. Here, to characterize circulating genotypes, we analysed 260 isolates sampled in Yemen between 2018 and 2019. Eighty-four percent of V. cholerae isolates were serogroup O1 belonging to the seventh pandemic El Tor (7PET) lineage, sub-lineage T13, whereas 16% were non-toxigenic, from divergent non-7PET lineages. Treatment of severe cholera with macrolides between 2016 and 2019 coincided with the emergence and dominance of T13 subclones carrying an incompatibility type C (IncC) plasmid harbouring an MDR pseudo-compound transposon. MDR plasmid detection also in endemic non-7PET V. cholerae lineages suggested genetic exchange with 7PET epidemic strains. Stable co-occurrence of the IncC plasmid with the SXT family of integrative and conjugative element in the 7PET background has major implications for cholera control, highlighting the importance of genomic epidemiological surveillance to limit MDR spread.

Citing Articles

Continued T12 transmission and shared antibiotic resistance during 2018-2023 Vibrio cholerae outbreaks in Cameroon.

Ngomtcho S, Akenji B, Ndip R, Azman A, Tayimetha Y, Guenou E PLOS Glob Public Health. 2025; 5(2):e0003763.

PMID: 39992999 PMC: 11849833. DOI: 10.1371/journal.pgph.0003763.


A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia.

Islam M, Nahar K, Ara N, Biswas S, Waliullah , Tasnim J Gut Pathog. 2024; 16(1):76.

PMID: 39702517 PMC: 11660620. DOI: 10.1186/s13099-024-00655-3.


Draft genomes of 10 isolates collected in Sudan in 2019.

Adam M, Sims S, Awad A, Meredith L, Mohamed Ahmed B, Ahmed R Microbiol Resour Announc. 2024; 13(11):e0037624.

PMID: 39382321 PMC: 11556115. DOI: 10.1128/mra.00376-24.


Antibacterial action, proteolytic immunity, and in vivo activity of a Vibrio cholerae microcin.

Kim S, Randall J, Gu R, Nguyen Q, Davies B Cell Host Microbe. 2024; 32(11):1959-1971.e6.

PMID: 39260372 PMC: 11563924. DOI: 10.1016/j.chom.2024.08.012.


Genomic analysis of O1 isolates from cholera cases, Europe, 2022.

Rouard C, Greig D, Tauhid T, Dupke S, Njamkepo E, Amato E Euro Surveill. 2024; 29(36).

PMID: 39239731 PMC: 11378513. DOI: 10.2807/1560-7917.ES.2024.29.36.2400069.


References
1.
Dureab F, Ahmed K, Beiersmann C, Standley C, Alwaleedi A, Jahn A . Assessment of electronic disease early warning system for improved disease surveillance and outbreak response in Yemen. BMC Public Health. 2020; 20(1):1422. PMC: 7501711. DOI: 10.1186/s12889-020-09460-4. View

2.
Federspiel F, Ali M . The cholera outbreak in Yemen: lessons learned and way forward. BMC Public Health. 2018; 18(1):1338. PMC: 6278080. DOI: 10.1186/s12889-018-6227-6. View

3.
Mutreja A, Kim D, Thomson N, Connor T, Lee J, Kariuki S . Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011; 477(7365):462-5. PMC: 3736323. DOI: 10.1038/nature10392. View

4.
Weill F, Domman D, Njamkepo E, Almesbahi A, Naji M, Nasher S . Genomic insights into the 2016-2017 cholera epidemic in Yemen. Nature. 2019; 565(7738):230-233. PMC: 6420076. DOI: 10.1038/s41586-018-0818-3. View

5.
Rabaan A . Cholera: an overview with reference to the Yemen epidemic. Front Med. 2018; 13(2):213-228. DOI: 10.1007/s11684-018-0631-2. View